Article
Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient.
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2022
Danandeh Khashayar, Jabbari Parnian, Rayzan Elham, Zoghi Samaneh, Shahkarami Sepideh, Heredia Raul Jimenez, Krolo Ana, Shamsian Bibi Shahin, Boztug Kaan, Rezaei Nima
Abstract excerpt
BACKGROUND: Lymphoproliferative disorders include a heterogeneous list of conditions that commonly involve dysregulation of lymphocyte proliferation resulting in lymphadenopathy and bone marrow infiltration. These disorders have various presentations, most notably autoimmune manifestations, organomegaly, lymphadenopathy, dysgammaglobulinemia, and increased risk of chronic infections. CASE PRESENTATION: A young...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
